Glenview Trust Co Buys New Holdings in Humana Inc. $HUM

Glenview Trust Co purchased a new position in Humana Inc. (NYSE:HUM) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 43,688 shares of the insurance provider’s stock, valued at approximately $17,354,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Montag A & Associates Inc. increased its position in shares of Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Humana during the 2nd quarter worth $26,000. Fideuram Asset Management Ireland dac purchased a new stake in shares of Humana during the 4th quarter worth $27,000. Trust Co. of Vermont acquired a new position in shares of Humana during the second quarter worth $28,000. Finally, Reflection Asset Management acquired a new position in shares of Humana during the fourth quarter worth $29,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Wells Fargo & Company upgraded Humana from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $227.00 to $502.00 in a research note on Monday, July 13th. Wolfe Research reaffirmed an “outperform” rating and set a $450.00 price objective on shares of Humana in a research report on Monday. Bank of America upgraded Humana from a “neutral” rating to a “buy” rating and set a $500.00 price objective on the stock in a report on Wednesday, July 29th. UBS Group began coverage on Humana in a research report on Thursday, July 30th. They set a “buy” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft started coverage on Humana in a research note on Thursday, July 30th. They set a “hold” rating for the company. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Humana has an average rating of “Hold” and a consensus target price of $403.91.

Humana Price Performance

Shares of NYSE:HUM opened at $392.72 on Friday. The company’s fifty day moving average price is $385.08 and its 200 day moving average price is $287.78. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a market capitalization of $47.16 billion, a P/E ratio of 37.15, a P/E/G ratio of 2.23 and a beta of 0.72.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. Humana’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.27 earnings per share. As a group, sell-side analysts predict that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.